Angiotensin Inhibiting Agents

The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system

The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system

Most notably, this grouping includes angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), alongside direct renin inhibitors

Most notably, this grouping includes angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), alongside direct renin inhibitors These agents work by preventing the formation of angiotensin II or selectively blocking its binding to vascular receptors, which promotes vasodilation, reduces systemic vascular resistance, and decreases aldosterone secretion Clinically, these medications serve as foundational therapies across major cardiovascular and renal conditions,...

Clinically, these medications serve as foundational therapies across major cardiovascular and renal conditions, including hypertension, heart failure with reduced ejection fraction, post-myocardial infarction ventricular dysfunction, and chronic kidney disease, particularly diabetic nephropathy